NEPHROS INC·4

Dec 16, 9:17 PM ET

Gwydir Tom 4

4 · NEPHROS INC · Filed Dec 16, 2021

Insider Transaction Report

Form 4
Period: 2021-12-14
Gwydir Tom
Director
Transactions
  • Award

    Common Stock

    2021-12-14+4,58215,613 total
  • Award

    Stock Option (right to buy)

    2021-12-14+7,0627,062 total
    Exercise: $6.82Exp: 2031-12-14Common Stock (7,062 underlying)
Holdings
  • Stock Option (right to buy)

    Exercise: $5.31Exp: 2029-04-29Common Stock (9,627 underlying)
    9,627
  • Stock Option (right to buy)

    Exercise: $8.57Exp: 2029-12-16Common Stock
    5,568
  • Stock Option (right to buy)

    Exercise: $8.06Exp: 2031-01-06Common Stock
    6,850
Footnotes (4)
  • [F1]Represents shares of restricted stock granted to the reporting person in lieu of cash fees payable to the reporting person for his service on the Company's Board of Directors. These shares of restricted stock vest 6 months following the grant date.
  • [F2]Fully exercisable.
  • [F3]This option vests as to 2,284 shares on 1/6/21 and as to 2,283 shares on each of 1/6/22 and 1/6/23.
  • [F4]Represents options granted to the reporting person for his service on the Company's Board of Directors. This option vests as to 2,354 shares on each of 12/14/21, 12/14/22 and 12/14/23.

Documents

1 file
  • 4
    rdgdoc.xmlPrimary

    FORM 4